Ann Neurol

1. SAKOWSKI SA, Koubek EJ, Chen KS, Goutman SA, et al
   Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions.
   Ann Neurol. 2024;95:635-652.
   

   >> Share

   
   

   
   J Neural Transm (Vienna)

2. MATSUI H, Takahashi R
   Current trends in basic research on Parkinson's disease: from mitochondria, lysosome to alpha-synuclein.
   J Neural Transm (Vienna). 2024 Apr 13. doi: 10.1007/s00702-024-02774.
   

   >> Share

   
   
3. SCHROTER N, Sajonz BEA, Jost WH, Rijntjes M, et al
   Advanced therapies in Parkinson's disease: an individualized approach to their indication.
   J Neural Transm (Vienna). 2024 Apr 13. doi: 10.1007/s00702-024-02773.
   

   >> Share

   
   
4. ABDULBAKI A, Wohrle JC, Blahak C, Weigel R, et al
   Somatosensory evoked potentials recorded from DBS electrodes: the origin of subcortical N18.
   J Neural Transm (Vienna). 2024;131:359-367.
   

   >> Share

   
   
5. FERRUCCI M, Lenzi P, Lazzeri G, Busceti CL, et al
   Combined light and electron microscopy (CLEM) to quantify methamphetamine-induced alpha-synuclein-related pathology.
   J Neural Transm (Vienna). 2024;131:335-358.
   

   >> Share

   
   

   
   J Neurol Neurosurg Psychiatry

6. YIN Z, Yuan T, Yang A, Xu Y, et al
   Contribution of basal ganglia activity to REM sleep disorder in Parkinson's disease.
   J Neurol Neurosurg Psychiatry. 2024 Apr 19:jnnp-2023-332014.
   

   >> Share

   
   
7. MAK JKL, McMurran CE, Hagg S
   Clinical biomarker-based biological ageing and future risk of neurological disorders in the UK Biobank.
   J Neurol Neurosurg Psychiatry. 2024;95:481-484.
   

   >> Share

   
   

   
   JAMA

8. GIBBONS CH, Levine T, Adler C, Bellaire B, et al
   Skin Biopsy Detection of Phosphorylated alpha-Synuclein in Patients With Synucleinopathies.
   JAMA. 2024 Mar 20:e240792. doi: 10.1001/jama.2024.0792.
   

   >> Share

   
   

   
   Lancet Neurol

9. TOFT M
   New gene involved in the pathogenesis of Parkinson's disease.
   Lancet Neurol. 2024 Apr 10:S1474-4422(24)00166.
   

   >> Share

   
   
10. GUSTAVSSON EK, Follett J, Trinh J, Barodia SK, et al
    RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
    Lancet Neurol. 2024 Apr 10:S1474-4422(24)00121.
    

    >> Share

    
    

    
    Mov Disord

11. WANG Y, Li H, Song N, Xie J, et al
    Yeast Prion Protein Sup35 Initiates alpha-Synuclein Pathology in Parkinson's Disease.
    Mov Disord. 2024 Apr 16. doi: 10.1002/mds.29810.
    

    >> Share

    
    
12. LASS J, Luth T, Schluter K, Schaake S, et al
    Stability of Mosaic Divergent Repeat Interruptions in X-Linked Dystonia-Parkinsonism.
    Mov Disord. 2024 Apr 14. doi: 10.1002/mds.29809.
    

    >> Share

    
    

    
    Nat Med

13. PAGANO G, Taylor KI, Anzures Cabrera J, Simuni T, et al
    Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.
    Nat Med. 2024;30:1096-1103.
    

    >> Share

    
    

    
    Nervenarzt

14. DODEL R, Berg D, Duning T, Kalbe E, et al
    [Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and diagnostics].
    Nervenarzt. 2024;95:353-361.
    

    >> Share

    
    
15. DODEL R, Berg D, Duning T, Kalbe E, et al
    [Dementia with Lewy bodies: old and new knowledge-Part 2: treatment].
    Nervenarzt. 2024;95:362-367.
    

    >> Share

    
    

    
    Neurochem Res

16. VASUDEVAN SAJINI D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN, et al
    Correction: Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
    Neurochem Res. 2024 Apr 16. doi: 10.1007/s11064-024-04138.
    

    >> Share

    
    

    
    Neurologia (Engl Ed)

17. PEREZ-TORRE P, Lopez-Sendon JL, Mananes Barral V, Parees I, et al
    Concomitant treatment with safinamide and antidepressant drugs: Safety data from real clinical practice.
    Neurologia (Engl Ed). 2024;39:340-344.
    

    >> Share

    
    
18. LUIZ LMD, Marques IA, Folador JP, Andrade AO, et al
    Intra and inter-rater remote assessment of bradykinesia in Parkinson's disease.
    Neurologia (Engl Ed). 2024;39:345-352.
    

    >> Share

    
    

    
    Neurology

19. DOPPLER CEJ, Seger A, Farrher E, Regio Brambilla C, et al
    Glutamate Signaling in Patients With Parkinson Disease With REM Sleep Behavior Disorder.
    Neurology. 2024;102:e209271.
    

    >> Share

    
    

    
    PLoS One

20. SONG J, Li J, Pei X, Chen J, et al
    Identification of cuproptosis-realated key genes and pathways in Parkinson's disease via bioinformatics analysis.
    PLoS One. 2024;19:e0299898.
    

    >> Share

    
    
21. ANJUM R, Raza C, Faheem M, Ullah A, et al
    Neuroprotective potential of Mentha piperita extract prevents motor dysfunctions in mouse model of Parkinson's disease through anti-oxidant capacities.
    PLoS One. 2024;19:e0302102.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

22. MOHD RAFIQ N, Fujise K, Rosenfeld MS, Xu P, et al
    Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons.
    Proc Natl Acad Sci U S A. 2024;121:e2318943121.
    

    >> Share

    
    

    
    Rev Neurol

23. DURAN-NAVARRETE MJ, Soto-Voitmann MJ, Torres-Araneda G, Lagos-Gutierrez LD, et al
    [Effects on cognitive processes of dual-task training in people with Parkinson's disease: a systematic review].
    Rev Neurol. 2024;78:219-228.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share